Atossa Therapeutics (Germany) Technical Analysis
| YAG2 Stock | 1.22 0.02 1.67% |
As of the 29th of November, Atossa Therapeutics shows the Mean Deviation of 2.29, standard deviation of 3.37, and Risk Adjusted Performance of 0.0039. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Atossa Therapeutics, as well as the relationship between them.
Atossa Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Atossa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AtossaAtossa |
Atossa Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Atossa Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Atossa Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Atossa Therapeutics Trend Analysis
Use this graph to draw trend lines for Atossa Therapeutics. You can use it to identify possible trend reversals for Atossa Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Atossa Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Atossa Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Atossa Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0008 , which may suggest that Atossa Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.03, which is the sum of squared deviations for the predicted Atossa Therapeutics price change compared to its average price change.About Atossa Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Atossa Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Atossa Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Atossa Therapeutics price pattern first instead of the macroeconomic environment surrounding Atossa Therapeutics. By analyzing Atossa Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Atossa Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Atossa Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Atossa Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Atossa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Atossa from various momentum indicators to cycle indicators. When you analyze Atossa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0039 | |||
| Market Risk Adjusted Performance | (0.14) | |||
| Mean Deviation | 2.29 | |||
| Coefficient Of Variation | (19,787) | |||
| Standard Deviation | 3.37 | |||
| Variance | 11.37 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.15) | |||
| Maximum Drawdown | 17.95 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.35 | |||
| Skewness | 0.381 | |||
| Kurtosis | 1.52 |
Additional Tools for Atossa Stock Analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.